Slingshot members are tracking this event:
CTI BioPharma Initiates Rolling Submission of U.S. New Drug Application for Pacritinib for the Treatment of Patients with Myelofibrosis, Completion date overdue
Slingshot Insights Explained
Feb 09, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Nda, Pacritinib, Myelofibrosis